Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine
Vansteenkiste, J. F., Vandebroek, J. E., Nackaerts, K. L., Weynants, P., Valcke, Y. J., Verresen, D. A., Devogelaere, R. C., Marien, S. A., Humblet, Y. P., Dams, N. L.
Published in Annals of oncology (01.09.2001)
Published in Annals of oncology (01.09.2001)
Get full text
Journal Article
Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship?
Verresen, D, De Backer, W, Van Meerbeeck, J, Neetens, I, Van Marck, E, Vermeire, P
Published in The European respiratory journal (01.05.1991)
Published in The European respiratory journal (01.05.1991)
Get full text
Journal Article
A randomized phase II feasibility study of adjuvant cisplatin/docetaxel (CisD) or cisplatin/vinorelbine (CisV) in patients (pts) resected stage IB-II non-small cell lung cancer (NSCLC): Interim analysis
Galdermans, D., Driesen, P., Bustin, F., Lambrechts, M., Deschepper, K., Stappaerts, I., Verresen, D., Janssens, A., Germonpré, P. R.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation in patients with unresectable stage III non-small-cell lung cancer (NSCLC): FEV1 as prognostic marker
Germonpré, P. R., Janssens, A., Van Moorter, L., Verresen, D., Galdermans, D., Devogelaere, R., Ottevaere, H., Mentens, Y., De Pooter, C., Goor, C.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article